शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
LOTUSEYENSELotus Eye Hospital and Institute Limited· Healthcare ServicesHighNeutral
Announced Wed, 12 Nov, 2025 · 18:10 IST

Q2 FY26 results: revenue flat, profit steady, margins under pressure

Exceptional itemEBITDA margin compressionResults View source PDFExplain this filing

LOTUSEYE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-1.4%Reaction day
₹118.00
prior close
₹116.15
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.1%-1.3% vs market
Hospital peers, median of 18sector-0.5%-0.9% vs sector

On the reaction day the stock moved 1.3 pts less than Nifty Microcap 250 and 0.9 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-1.0
10m
-1.0
15m
-0.6
30m
-1.3
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-1.4-0.1-1.3-0.5-0.9
Next day
-7.2-0.2-7.0-0.6-6.6
2d
-10.2+0.4-10.6+0.5-10.6
3d
-12.7-0.4-12.3-1.0-11.7
4d
-11.3-0.6-10.8-1.3-10.1
5d
-10.2-0.9-9.3-0.9-9.3
1w
-11.0-3.0-8.0-1.5-9.5
15d
-10.8-3.9-6.9-3.0-7.8
1m
+11.5-4.8+16.3-3.3+14.8
2m
-6.8-7.8+1.0-7.3+0.6
3m
-4.3-7.2+2.9-10.1+5.8
UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 18Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Lotus Eye Hospital reported Q2 FY26 revenue of Rs 1,303.84 lakhs, nearly flat YoY versus Rs 1,291.24 lakhs. H1 FY26 revenue grew modestly to Rs 2,655.53 lakhs. Net profit for H1 FY26 stood at Rs 9.42 lakhs vs Rs 8.82 lakhs last year. Exceptional items of Rs 79.95 lakhs (H1) from PPE sale boosted pre-tax profits. EBITDA margins shrank from about 13% to 10% YoY, reflecting higher costs. Auditor issued a clean limited review report.

Likely market impact

Flat revenue and shrinking margins signal cost pressure; exceptional PPE sale lifted headline profit. Watch for margin recovery in coming quarters.